Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2001-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known whether gemcitabine plus CI-994 is more
effective than gemcitabine alone for non-small cell lung cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of gemcitabine with or
without CI-994 in treating patients who have advanced non-small cell lung cancer.